1 |
Teworte S, Luciani P. Endometriosis, the Silent Disease: Molecular Targets, Active Principles, and Drug Delivery Systems. Helvetica Chimica Acta 2022. [DOI: 10.1002/hlca.202200132] [Reference Citation Analysis]
|
2 |
Fanse S, Bao Q, Burgess DJ. Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities. Adv Drug Deliv Rev 2022;191:114581. [PMID: 36270490 DOI: 10.1016/j.addr.2022.114581] [Reference Citation Analysis]
|
3 |
Li B, Zhang L, Xie Y, Lei L, Qu W, Sui L. Evaluation of pharmacokinetics and safety of a long-term estradiol-releasing stent in rat uterine. Regen Ther 2022;21:494-501. [PMID: 36313395 DOI: 10.1016/j.reth.2022.10.001] [Reference Citation Analysis]
|
4 |
Da L, Sun Y, Lin Y, Chen S, Chen G, Zheng B, Du S. Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues. Pharmaceutics 2022;14:1718. [DOI: 10.3390/pharmaceutics14081718] [Reference Citation Analysis]
|
5 |
das Neves J, Ensign L. Advances in drug delivery for women's health: A matter of gender equity. Adv Drug Deliv Rev 2022;182:114132. [PMID: 35090956 DOI: 10.1016/j.addr.2022.114132] [Reference Citation Analysis]
|